Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents-Reference-Cited by-同舟云学术

Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in endemic areas of Brazil: interim results of a double-blind, randomised, placebo-controlled phase 3 trial in adolescents

Published:2024-09 Issue: Volume: Page:
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Buerger Vera,Hadl Sandra,Schneider Martina,Schaden Michaela,Hochreiter Romana,Bitzer Annegret,Kosulin Karin,Mader Robert,Zoihsl Oliver,Pfeiffer Andrea,Loch Ana Paula,Morandi Eolo,Nogueira Mauricio Lacerda,de Brito Carlos Alexandre Antunes,Croda Julio,Teixeira Mauro Martins,Coelho Ivo Castelo-Branco,Gurgel Ricardo,da Fonseca Allex Jardim,de Lacerda Marcus Vinícius Guimarães,Moreira Edson Duarte,Veiga Ana Paula Rocha,Dubischar Katrin,Wressnigg Nina,Eder-Lingelbach Susanne,Jaramillo Juan Carlos

Funder

Horizon 2020

Coalition for Epidemic Preparedness Innovations

Publisher

Elsevier BV

Reference33 articles.

1. Dengue, Zika and chikungunya: emerging arboviruses in the new world;Patterson;West J Emerg Med,2016

2. Multiple roles of the non-structural protein 3 (nsP3) alphavirus unique domain (AUD) during chikungunya virus genome replication and transcription;Gao;PLoS Pathog,2019

3. Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial;Wressnigg;Lancet Infect Dis,2020

4. Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial;Schneider;Lancet,2023

5. A randomized, double-blinded phase 3 study to demonstrate lot-to-lot consistency and to confirm immunogenicity and safety of the live-attenuated chikungunya virus vaccine candidate VLA1553 in healthy adults;McMahon;J Travel Med,2024

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First immunogenicity and safety data on live chikungunya vaccine in an endemic area;The Lancet Infectious Diseases;2024-09